Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 21:58:09 UTC
Update Date2021-09-26 23:16:56 UTC
HMDB IDHMDB0259408
Secondary Accession NumbersNone
Metabolite Identification
Common NameCyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-
DescriptionN-[2-ethanesulfonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboximidic acid belongs to the class of organic compounds known as n-arylamides. These are organic compounds that contain a carboxamide group that is N-linked to a aryl group. They have the generic structure RC(=O)N(R')H, R = organyl group and R'= aryl group. Based on a literature review very few articles have been published on N-[2-ethanesulfonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Cyclohexanecarboxamide, n-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-[2-Ethanesulfonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboximidateGenerator
N-[2-Ethanesulphonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboximidateGenerator
N-[2-Ethanesulphonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboximidic acidGenerator
N-((2-Ethylsulfonylamino)-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide monohydrate sodium saltMeSH
Chemical FormulaC15H20F3N3O3S
Average Molecular Weight379.4
Monoisotopic Molecular Weight379.117747179
IUPAC NameN-[2-ethanesulfonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboxamide
Traditional NameN-[2-ethanesulfonamido-5-(trifluoromethyl)pyridin-3-yl]cyclohexanecarboxamide
CAS Registry NumberNot Available
SMILES
CCS(=O)(=O)NC1=C(NC(=O)C2CCCCC2)C=C(C=N1)C(F)(F)F
InChI Identifier
InChI=1S/C15H20F3N3O3S/c1-2-25(23,24)21-13-12(8-11(9-19-13)15(16,17)18)20-14(22)10-6-4-3-5-7-10/h8-10H,2-7H2,1H3,(H,19,21)(H,20,22)
InChI KeyTUWCZRFHNIOVTC-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as n-arylamides. These are organic compounds that contain a carboxamide group that is N-linked to a aryl group. They have the generic structure RC(=O)N(R')H, R = organyl group and R'= aryl group.
KingdomOrganic compounds
Super ClassOrganic nitrogen compounds
ClassOrganonitrogen compounds
Sub ClassN-arylamides
Direct ParentN-arylamides
Alternative Parents
Substituents
  • N-arylamide
  • Pyridine
  • Organic sulfonic acid amide
  • Organosulfonic acid amide
  • Imidolactam
  • Heteroaromatic compound
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Sulfonyl
  • Aminosulfonyl compound
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Azacycle
  • Carbonyl group
  • Alkyl halide
  • Organic oxide
  • Alkyl fluoride
  • Organosulfur compound
  • Organooxygen compound
  • Organofluoride
  • Organohalogen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organic oxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.02ALOGPS
logP3.11ChemAxon
logS-3.6ALOGPS
pKa (Strongest Acidic)7.31ChemAxon
pKa (Strongest Basic)-3.1ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area88.16 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity87.81 m³·mol⁻¹ChemAxon
Polarizability35.56 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+184.24530932474
DeepCCS[M-H]-181.58130932474
DeepCCS[M-2H]-216.17930932474
DeepCCS[M+Na]+191.81330932474
AllCCS[M+H]+182.932859911
AllCCS[M+H-H2O]+180.332859911
AllCCS[M+NH4]+185.332859911
AllCCS[M+Na]+186.032859911
AllCCS[M-H]-177.932859911
AllCCS[M+Na-2H]-178.132859911
AllCCS[M+HCOO]-178.532859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-CCS(=O)(=O)NC1=C(NC(=O)C2CCCCC2)C=C(C=N1)C(F)(F)F3988.7Standard polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-CCS(=O)(=O)NC1=C(NC(=O)C2CCCCC2)C=C(C=N1)C(F)(F)F2614.1Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-CCS(=O)(=O)NC1=C(NC(=O)C2CCCCC2)C=C(C=N1)C(F)(F)F2563.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1NC(=O)C1CCCCC1)[Si](C)(C)C2448.8Semi standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1NC(=O)C1CCCCC1)[Si](C)(C)C2708.4Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1NC(=O)C1CCCCC1)[Si](C)(C)C3482.6Standard polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TMS,isomer #2CCS(=O)(=O)NC1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C2400.5Semi standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TMS,isomer #2CCS(=O)(=O)NC1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C2621.5Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TMS,isomer #2CCS(=O)(=O)NC1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C3359.7Standard polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,2TMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C)[Si](C)(C)C2423.2Semi standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,2TMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C)[Si](C)(C)C2834.9Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,2TMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C)[Si](C)(C)C3151.7Standard polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TBDMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1NC(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C2688.4Semi standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TBDMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1NC(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C2964.3Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TBDMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1NC(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C3500.0Standard polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TBDMS,isomer #2CCS(=O)(=O)NC1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C2615.8Semi standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TBDMS,isomer #2CCS(=O)(=O)NC1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C2877.4Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,1TBDMS,isomer #2CCS(=O)(=O)NC1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C3401.2Standard polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,2TBDMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2824.7Semi standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,2TBDMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3350.6Standard non polar33892256
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-,2TBDMS,isomer #1CCS(=O)(=O)N(C1=NC=C(C(F)(F)F)C=C1N(C(=O)C1CCCCC1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3242.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)- GC-MS (Non-derivatized) - 70eV, Positivesplash10-004r-9164000000-2eddd7f3529485f5b45f2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)- GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID136140
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]